ArticleCell stem cell2019

MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.

Lorna R Fiedler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.